These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 38136371)
1. Functional and Molecular Heterogeneity in Glioma Stem Cells Derived from Multiregional Sampling. Brynjulvsen M; Solli E; Walewska M; Zucknick M; Djirackor L; Langmoen IA; Mughal AA; Skaga E; Vik-Mo EO; Sandberg CJ Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136371 [TBL] [Abstract][Full Text] [Related]
2. Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma. Skaga E; Kulesskiy E; Fayzullin A; Sandberg CJ; Potdar S; Kyttälä A; Langmoen IA; Laakso A; Gaál-Paavola E; Perola M; Wennerberg K; Vik-Mo EO BMC Cancer; 2019 Jun; 19(1):628. PubMed ID: 31238897 [TBL] [Abstract][Full Text] [Related]
3. Feasibility study of using high-throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatment. Skaga E; Kulesskiy E; Brynjulvsen M; Sandberg CJ; Potdar S; Langmoen IA; Laakso A; Gaál-Paavola E; Perola M; Wennerberg K; Vik-Mo EO Clin Transl Med; 2019 Dec; 8(1):33. PubMed ID: 31889236 [TBL] [Abstract][Full Text] [Related]
4. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration. Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830 [TBL] [Abstract][Full Text] [Related]
5. Metabolic profiling of glioblastoma stem cells reveals pyruvate carboxylase as a critical survival factor and potential therapeutic target. Renoult O; Laurent-Blond M; Awada H; Oliver L; Joalland N; Croyal M; Paris F; Gratas C; Pecqueur C Neuro Oncol; 2024 Sep; 26(9):1572-1586. PubMed ID: 38869884 [TBL] [Abstract][Full Text] [Related]
6. Genetically distinct glioma stem-like cell xenografts established from paired glioblastoma samples harvested before and after molecularly targeted therapy. Tanaka S; Luk S; Kiyokawa J; Onozato ML; Iafrate AJ; Shah K; Martuza RL; Rabkin SD; Batchelor TT; Cahill DP; Chi AS; Wakimoto H Sci Rep; 2019 Jan; 9(1):139. PubMed ID: 30644426 [TBL] [Abstract][Full Text] [Related]